MDS Virtual Congress 2020 Archives - Page 120 of 149

Machine Learning Predicts Clinically Important Improvement in Quality of Life after STN-DBS in Patients with Parkinson’s Disease

E. Rouleau, W. Potters, D. Pina Fuentes, M. Bot, J. Dijk, R. Schuurman, R. de Bie, M. Beudel (Amsterdam, Netherlands)
Magnetic Property Characterization of Deep Gray Matters in Patients with Alzheimer’s diseases, Dementia with Lewy Bodies and Parkinson’s Disease Dementia using Quantitative Susceptibility Mapping

J. Kim, K. Lee, S. Yoo, Y. Oh, S. Koh (Seoul, Republic of Korea)
Maintenance of safinamide 100 mg daily long-term

N. FONCEA (Galdakao, Spain)
Maladaptive motor cortex plasticity off medication in Parkinson’s disease patients with levodopa-induced dyskinesias

M. Dileone, C. Ammann, V. Catanzaro, R. Piredda, M.G Monje, I. Navalpotro-Gómez, A. Bergareche, L. Vela, F. Alonso-Frech, M.J Catalán-Alonso, J.A Molina, N. López-Ariztegui, F. Hernández-Fernández, B. Fernández-Rodríguez, C. Gasca-Salas, J.U Máñez-Miró, R. Martínez-Fernández, A. Sánchez-Ferro, A. Oliviero, J.A Obeso, G. Foffani (Móstoles, Spain)
Maladaptive use of LD/CD tablets as painkillers causing Dopamine Dysregulation Syndrome in 4 patients of Advanced Parkinson’s Disease

M. Gautam, K. Shukla, N. Sawal (Chandigarh, India)
Male-specific exacerbation of susceptibility to α-synuclein pre-formed fibrils by developmental dieldrin exposure in mice

A. Gezer, J. Kochmanski, S. VanOeveren, A. Cole-Strauss, C. Kemp, J. Patterson, K. Miller, N. Kuhn, D. Herman, A. McIntire, J. Lipton, K. Luk, S. Fleming, C. Sortwell, A. Bernstein (Grand Rapids, MI, USA)
Management of Cervical Dystonia & Spastic Paresis with Botulinum Neurotoxin-A: results from the INPUT survey

R. Bhidayasiri, L.J Jacinto, K. Bhatia, N. Dursun, T.M Chung, J. Tiley, C. Colosimo (Bangkok, Thailand)
Management of Dystonia in Europe from Patients’ Experience

M. Relja, V. Miletic (Zagreb, Croatia)
Management of neuropsychiatric symptoms in Parkinson’s disease (PD) at the front door

M.A Farooqi, A. Chatterjee (Reading, United Kingdom)
Management of parkinsonian patients with long-term DBS and incomplete control of symptoms

I. Reuter (Giessen, Germany)
Management practices and long-term follow up of pediatric functional (psychogenic) movement disorder at a tertiary care center

M. Hull, J.M Maldonado-Duran, M. Parnes (Houston, TX, USA)
Managing Functional Movement Disorder in Outpatient Physical Therapy: A Case Report of Belly-Dancer Dyskinesia

R. Hand, J. Snider, J. Utt (Richmond, VA, USA)
Mass spectrometry-based proteomics brain analysis to distinguish between Parkinson syndromes

A. Rajput, P. Chumala, B. Thompson, A. Rajput, G. Katselis (Saskatoon, SK, Canada)
May Safinamide have a Role in Atypical Parkinsonism? A Retrospective Study in Clinical Practice

F. Rodríguez Jorge, A. Beltrán Corbellini, J.L Chico García, P. Parra Díaz, P. Pérez Torre, B. Baena Álvarez, I. Parées Moreno, J.L López-Sendón, J.C Martínez Castrillo, A. Alonso Cánovas, S. Fanjul Arbós (Madrid, Spain)
Mcleod syndrome: Systematic review with meta-analysis

A. Rochel Pérez, O. Cuevas Koh, K. Santos Zaldivar, R. Leal Ortega, R. Janssen-Aguilar, N. Mendez Dominguez (Mérida, Mexico)
MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS

S. Luo, N. LaPelle, P. Martin, C. Goetz, G. Stebbins (Durham, NC, USA)
MDSGene Systematic Review: Genotype-Phenotype Relations for Hereditary Spastic Paraplegia Genes SPAST, ATL1 & REEP1

C. Kang, J. Huang, R. Rajalingam, A. Rasheed, J. Zhang, Z. Walls, M. Hamed, M. Breza, S. Schaake, J. Massa, R. Massa, A. Shetty, C. Sue, R. Schule, F. Cambi, O. Suchowersky, F. Vulinovic, S. Petkovic, C. Klein, K. Lohmann, C. Marras, K. Kumar (St Leonards, Australia)
Measure of Social Relation in Huntington’s Disease: The Relationship Self-Questionnaire (RSQ)

J. Hamet Bagnou, R. Massart, K. Hernandez, R. Fliss, M. Lunven, E. Audureau, A.C Bachoud-Levi (Creteil, France)
Measurement of speech as a biomarker of neurodegenerative disease using acoustic profiles and machine learning

B. Schultz, Z.. Joukhader, U. Nattala, G. Noffs, J. Chan, S. Rojas-Azaocar, H. Reece, M. Magee, M. Delatycki, L. Corben, A. Walt, A. Vogel (Melbourne, Australia)
Measuring Unmet Need in Underserved Parkinson’s Populations (UPPs)

S. Rosenfeld, M. Feeney, V. Todaro, A. Willis (New York, NY, USA)
Mechanisms of chronic neuroleptic-induced parkinsonism examined with positron emission tomography

M. Galoppin, P. Berroir, J. Soucy, E. Stip, P. Blanchet (Montreal, QC, Canada)
Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic

C. Taylor, C. Johnson, J. Marsh, L. Brown, A. Silverwood, R. Stringer, C. Cooper, R. Skelly (Derby, United Kingdom)
Meynert Nucleus-related Cortical Thinning in Parkinson’s Disease with Mild Cognitive Impairment

S.M Rong, Y. Li, B. Li, K. Nie, P. Zhang, TT. Cai, M.J Mei, L.J Wang, Y.H Zhang (Guangzhou, China)
Microbiome from Parkinson’s patients shows an increase in polyamines metabolism and differentially expresses microbial bacterial taxa compared to aged-matched normal controls

S. Melgar, N. Danso, C. Pena, J. Ahmed, S. Kumar, R. Kumar, C. Carlin, D. Linseman, D. Paredes (Denver, CO, USA)
Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder

K. Stær, A. Iranzo, M. Stokholm, K. Østergaard, M. Serradell, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus N, Denmark)
Microstructural changes in GBA mutation carriers with depression

H. Wilson, E. de Natale, M. Politis (London, United Kingdom)
Midbrain/pons area ratio and clinical features predict the prognosis of Progressive Supranuclear Palsy

S-S. Cui, Y-Y. Tan, S.D Chen (Shanghai, China)
Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus

H. Bejr-kasem, J. Pagonabarraga, F. Sampedro, S. Martínez-Horta, R. Perez-Gonzalez, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, A. Campolongo, C. Izquierdo, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
miRNA sequencing from routine colonic biopsies reveals an enrichment of submucosal hsa-miRNA-486-5p in Parkinson’s disease

A. Kurz, R. Kumar, C. Wenk, B. Nordhoff, J. Schirra, S. Donakonda, G. Höglinger, K. Bötzel, L. Holdt, T. Koeglsperger (Munich, Germany)
Mixed pathologies in pancreatic beta-cells from subjects with neurodegenerative diseases and their interaction with prion protein

R. Valenti, I. Martinez, I. Amat, I. Marcilla, G. Marti, L. Armengou, C. Caballero, M.R Luquin (Pamplona, Spain)
Modeling Cerebellar Limb Dysmetria and Impaired Spatial Memory in Rats Using Lamivudine: A preliminary study

E. Akang, O. Dosumu, S. Afolayan, R. Agumah, A. Oremosu, A. Akanmu (Lagos, Nigeria)
Modelling Huntington’s disease diagnosed prevalence from diagnosed incidence and survival time

V. Crowell, R. Houghton, F. Squitieri, A. Tomar, T. Fernandes (Basel, Switzerland)
Moderate-intensity balance training improve postural control in people with Parkinson’s disease

J. Szymura, J. Kubica, M. Wiecek, J. Pera (Krakow, Poland)
Moderately frequent and private variants in PRKN are associated with late-onset Parkinson’s disease

F. Hopfner, S.M Müller, SS. Szymczak, O. Junge, L. Tittmann, S. May, K. Lohmann, G. Grallert, B. Schormair, J. Winkelmann, B. Mollenhauer, C. Trenkwalder, W. Maetzler, D. Berg, M. Kasten, C. Klein, G. Hoeglinger, T. Gasser, G. Deuschl, A. Franke, M. Krawczak, A. Dempfle, G. Kuhlenbäumer (Hannover, Germany)
Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease

E. Forbes, T. Tropea, S. Mantri, J. Morley (Philadelphia, PA, USA)
Modulation of Basal Ganglia and Internal Capsule Fiber Tracts During Deep Brain Stimulation for Tourette Syndrome

K. Johnson, T. Foltynie, M. Hariz, L. Zrinzo, E. Joyce, Z. Kefalopoulou, P. Limousin, H. Akram, D. Servello, A. Bona, M. Porta, J.G Zhang, F.G Meng, Z. Ling, X. Xu, X. Yu, A. Leentjens, A. Smeets, L. Ackermans, L. Almeida, A. Gunduz, W. Hu, K. Foote, M. Okun, C. Butson (Salt Lake City, UT, USA)
Monitoring electrophysiological recordings in patients with LCIJ therapy

D. Gunal, H. Ozden, S. Irmak, K. Uluc (Istanbul, Turkey)
Monitoring gait in Parkinson’s disease (PD) at home with connected insoles: a feasibility study

L. farid, A.S rolland, G. Baille, D. Jacobs, E. Bezard, L. Defebvre, A. Delval, D. Devos, D. Guehl, C. Moreau (Lille, France)
Morphological changes of retina in patients with Parkinson’s disease and the role of α-synuclein in retinal damage

L. Man, Z. Wei (Chengdu, China)
Morphology and Signal Changes of the Lentiform Nucleus Based on Susceptibility Weighted Imaging in Parkinsonism predominant Multiple System Atrophy

C.P Zhao, Q.G Ren (Qindao, China)
Motor and cognitive symptoms in parkinsonism are associated with loss of long-range white matter fibers: Structural network changes in Vascular Parkinsonism and Parkinson’s disease

C. Cooper, B. Marebwa, F. Rodriguez-Porcel, T. Turner, G. Revuelta, J. Jensen, V. Hinson, L. Bonilha (Charleston, SC, USA)
Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)
Motor asymmetry in Parkinson’s disease: relation with freezing of gait

Z. Katzir, G. Zeilig, S. Israeli-Korn, S. Hassin-Baer, M. Plotnik (Ramat Gan, Israel)
Motor cerebellar connectivity and future development of freezing of gait in de novo Parkinson’s disease

J.H Jung, B.H Kim, S.J Chung, H.S Yoo, Y.H Lee, K. Baik, B.S Ye, Y.H Sohn, J.M Lee, P.H Lee (Seoul, Republic of Korea)
Motor Fluctuations in a Real-World Sample of Patients with Parkinson’s Disease

M. Serbin, S. Odak, C. Macahilig, N. Joshi, A. Shah, X. Ng, K. Olson, G. Liang, O. Klepitskaya, C. Yonan (San Diego, CA, USA)
Motor network deficits during lower limb movements in Parkinson’s disease

R. Burciu (Newark, DE, USA)
Motor onset of Parkinsonʼs disease: Is there a somatotopic pattern?

M. Monje, A. Sánchez-Ferro, L. Vela-Desojo, F. Alonso-Frech, M. Di Leone, J. Pineda-Pardo, G. Foffani, J. Obeso (Móstoles, Madrid, Spain)
Motor subtype change between OFF and ON periods in patients with Parkinson’s disease

O. Esquivel-Zapata, A. Abundes-Corona, F. Herrera-Rodriguez, O. Cardenas-Saenz, E. Escobar-Valdivia, Y. Ríos-Solís, H. Tellez-Lucero, A. Cervantes-Arriaga, M. Rodriguez-Violante (Mexico, Mexico)
Motor- and Non-motor Symptoms in Patients Treated with 24-hour Daily Levodopa-Carbidopa Intestinal Gel Infusion: Analysis of the COSMOS Observational Study

N. Kovács, J. Szász, L. Vela-Desojo, P. Svenningsson, S. Femia, J. Carlos Parra, A. Fasano (Pécs, Hungary)
Motor, non-motor and cognitive correlates of carotid intima-media thickness in patients with Parkinson’s disease

S. Castillo-Torres, C. Soto-Rincón, D. Martínez-Roque, J. Duarte-Bravo, S. España-Pérez, D. Cantú-García, A. Mendoza-García, L. Olguín-Ramírez, E. García-Valadez, B. Chávez-Luévanos, I. Estrada-Bellmann, F. Góngora-Rivera (Monterrey, NL, Mexico)
MOve To ImprovE physical activity in Parkinson’s disease (MOTIvatE): A pilot randomized clinical trial of gamification

N. Dahodwala, M. Engeland, W. Kerr, L. Walsh, M. Patel (Philadelphia, PA, USA)
Movement Disorders After Bariatric Surgeries – Case Series

G. Fabiani, C.H Camargo, H. Teive (Curitiba, Brazil)
Movement Disorders Analysis Using a Deep Learning Approach

C. Desjardins, Q. Salardaine, G. Vignoud, B. Degos (Bobigny, France)
Movement disorders and it association with immunological causes: the key is in the movement

E.M Gatto, G. Da Prat, J.L Etcheverry, M.E Cesarini, N. Gonzalez Rojas (CABA, Argentina)
Movement disorders associated with expansions and intermediate repeats in the C9orf72 gene

C. Estevez-Fraga, F. Magrinelli, A. Latorre, S. Tabrizi, H. Houlden, K. Bhatia (London, United Kingdom)
Movement disorders in a family carrying ATP7A variant

G. Buongarzone, B. Minafra, E. Errichiello, S. Gana, A. Asaro, I. Canavero, E. Tartara, M. Paoletti, R. Zangaglia, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)
Movement Disorders in Spanish Cathedrals

P.J Garcia-Ruiz, J.C Martinez Castrillo, L. Diaz Feliz (Madrid, Spain)
Movement Disorders in the Plain People

Z. Ammous (Topeka, IN, USA)
MR Conditional Labeling for DBS – Basic Physics for the Non-Specialist

M. Conroy, S. Falowski, D. Sayed, L. Poree, K. Chakravarthy, R. Banerjee, J. Kramer (Minneapolis, MN, USA)
MRI evaluation of Progressive Supranuclear Palsy

M. Kamada (Kagawa, Japan)
MRI findings in a 65-year old female with movement disorder

X.Y Li, L. Wang, X.H Wan (Beijing, China)
MRI functional connectivity analysis for speech impairment in Parkinson’s disease

J.P Niguet, R. Viard, T. Guichoux, A. Basirat, L. Defebvre, G. Kuchcinski, D. Devos, C. Moreau (Lille, France)
MRI guided high-intensity focused ultrasound thalamotomy for essential tremor: efficacy and safety at 1 year follow up

V. Livneh, S. Israeli korn, G. Yahalom, T. Fay-Karmon, Z. Zibly, R. Spiegelmann, S. Baer (Ramat gan, Israel)
mRNA level and variants of the SCARB2 gene in the pathogenesis of Parkinson’s disease

T. Usenko, A. Bezrukova, D. Bogdanova, A. Kopytova, A. Emelyanov, I. Miliukhina, A. Timofeeva, S. Pchelina (Gatchina, Russian Federation)
Multi-level and multi-pattern lower- and upper-limb spasticity treatment with incobotulinumtoxinA in children and adolescents with cerebral palsy

E. Dabrowski, H. Chambers, F. Heinen, P. Kaňovský, S. Schroeder, M. Banach, H. Dersch, T. Geister, F. Martinez-Torres, I. Pulte, D. Gaebler-Spira (Royal Oak, MI, USA)
Multimodal EEG-MRI based machine learning model in identifying Parkinson’s disease with mild cognitive impairment

J.H Zhang, L.J Wang, K. Nie (Guangzhou, China)
Multimodal model of Parkinson’s disease highlights differences in progression profiles of RBD patients

R. Couronné, A. Valladier, M. Vidailhet, J.C Corvol, S. Lehericy, S. Durrleman (Paris, France)
Multimodal neuroimaging during motor tasks in upper limb dystonia

A.J Paulo, D. de Faria, R. Dalle Lucca, J. Balardin, J. Sato, C. Baltazar, B. Machado, V. Borges, S. Silva, H. Ferraz, P. Aguiar (Sao Paulo, Brazil)
Multiplex biomarker discovery for diagnostic and progression markers for Parkinson’s disease with the proximity extension assay technology on inflammation-related analytes

M. Bartl, M. Dakna, S. Schade, B. Otte, C. Trenkwalder, B. Mollenhauer (Göttingen, Germany)
Music-based interventions for the management of movement disorders: a systematic literature review

S. Saade-Lemus, J. Martin-Saavedra, A. Deik (Philadelphia, PA, USA)
Mutation screening and clinical features analysis in patients with early-onset primary dystonia

X.J Gu, J. Yang, L.Y Zhang, QQ. Wei, H.F Shang (Chengdu, China)
Mutations of COX20 affect the assembly and function of complex IV causing early onset ataxia, dystonia and neuropathy

Y.M Liu, P.Z Li, DD. Guo, H.B LV, Y.L Zhang (Jinan, China)
Myoclonic epilepsy with ragged-red fibers: the first described clinical case in Ukraine

Y. Trufanov, N. Svyrydova, A. Galusha, V. Sereda, V. Svistun, I. Zarashchak, A. Yanchak (Kyiv, Ukraine)